Industry News
US man first to receive Sirtex cancer treatment
Anti-cancer treatment SIR-Spheres, designed by Sydney-based company Sirtex, has been used on a patient for the first time since it received US Food and Drug Administration (FDA) approval in March this year. [ + ]
Diabetes research offensive launched
A research and development agreement with the aim of finding an effective treatment for type II diabetes has been signed in Melbourne. [ + ]
Melbourne researchers discover heart attack gene link
Australian researchers have determined three genetic loci which are linked to heart attacks. [ + ]
Industry-minded CRCs awarded
Four Cooperative Research Centres (CRCs) have been honoured for their effective collaborations with industry. [ + ]
From virtual to functional: ES Cell opens new lab
Greater collaborative research opportunities are expected to result from the formal opening today of ES Cell International's new Australian research and development facility. [ + ]
Plantic gears up for market
Biodegradable packaging manufacturer Plantic Technologies has secured $4.5 million in venture capital and believes it will be in a position to service the Australian market within three months. [ + ]
Researchers fume as facility funding lags
Frustration is mounting for bioscience research facilities facing delays in grants promised under the $150 million Major National Research Facility scheme. [ + ]
Gradipore names new CEO
Sydney separation technology specialist Gradipore has appointed Robert Lieb as its new global CEO and vice-chairman. [ + ]
New Victorian research precinct opens
Victorian Premier Steve Bracks today opened the Alfred Medical Research and Education Precinct (AMREP), in Melbourne. [ + ]
Consultation body named
The Federal government has named the eight people who will help to set Australia's national research priorities. [ + ]
Looking for new treatments: Meditech and LEI team up
Meditech Research and the Lion's Eye Institute (LEI) have signed a licence agreement allowing LEI to use patents owned by Meditech in developing products for the prevention and treatment of eye diseases. [ + ]
Waste CRC boss warns on revenue expectations
Some Cooperative Research Centres (CRCs) could struggle to meet their seven-year revenue projections, the annual CRC Association conference in Sydney has been told. [ + ]
ASX or Nasdaq? Acrux investigates listing opportunities
Transdermal drug delivery company Acrux is planning a public listing in the next year but is yet to decide whether it will be on an Australian or United States bourse. [ + ]
Academy welcomes reappointment of Chief Scientist
The Australian Academy of Science has applauded the reappointment of the Federal Government’s Chief Scientist, Dr Robin Batterham, for a further three-year term.
[ + ]Amrad, Circadian compromise on board future
An 11th-hour resolution has ended a boardroom stoush between Amrad Corporation and Circadian Technologies. [ + ]